Skip to main content

ABI/MDS Sciex Inks LC/MS-APPI Cross License With Syagen Tech

NEW YORK (GenomeWeb News) — Applied Biosystems and MDS Sciex have signed a cross licensing agreement with Syagen Technology, a mass-spectrometry and analytical-instruments company, to share patents covering atmospheric pressure photo-ionization, Syagen said today.
 
Under the agreement, Syagen will supply its PhotoMate APPI source to the majority of the liquid chromatography/mass spectrometry instrument manufacturers, and the ABI/MDS Sciex joint venture will supply the Photospray APPI source to customers of its LC/MS product line.
 
According to Syagen, APPI complements electrospray ionization by expanding the “range of classes of compounds that can be analyzed with LC/MS instruments,” and by showing a decreased amount of ion suppression than other types of ionization sources.
 
Financial terms of the agreement were not released.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.